Xtrackers DAX UCITS ET (DBXD.ETF)

Cours de clôture: 209.15 (+1.50), 25. avr 2025
Conclusion légèrement positive

Bas risk

Automatic technical analysis. Moyen terme, 25. avr 2025

Xtrackers DAX UCITS ETF 1C fluctue dans un canal haussier et une progression poursuivant le canal haussier est indiquée. En cas de corrections à la baisse il y a du support en bas du canal haussier. Le titre est en repli après le franchissement de la formation rectangulaire. Il y a de la résistance à environ, 210, ce qui ouvre à des possibilités intéressantes de vente. Un franchissement établi au-dessus de cette résistance peut neutraliser le signal de vente donné. Le ETF rencontre du support à environ 185 euro et de la résistance à environ 220 euro. La balance des volumes est négative et affaiblit la valeur sur le court terme. Le ETF est généralement considéré comme légèrement positif technique pour moyen long terme.

Recommendation one to six months: Conclusion légèrement positive (Score: 38)

Période  
Vol.bal. Volatilité Liquidité +/- %
1 jour-0.70%8.86+0.72%
5 jours39.982.28%9.99+4.42%
22 jours-44.405.88%17.18-2.81%
66 jours-38.7211.50%13.67+5.91%

More analyses of Xtrackers DAX UCITS ETF 1C

chart Xtrackers DAX UCITS ETF 1C (DBXD) Chandeliers 22 Days
Candlesticks
chart Xtrackers DAX UCITS ETF 1C (DBXD) Court terme
Court terme: Conclusion légèrement négative
chart Xtrackers DAX UCITS ETF 1C (DBXD) Moyen terme
Moyen terme: Conclusion légèrement positive
chart Xtrackers DAX UCITS ETF 1C (DBXD) Long terme
Long terme : Positif
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.